Accendra Health任命新首席执行官

• Accendra Health (ACH) named board member Kenneth Gardner-Smith as its next president and CEO, with the appointment expected to take effect early in Q4 2026.
• Gardner-Smith will succeed Edward A. Pesicka, who announced his retirement in August after more than seven years leading the company.
• Gardner-Smith has served on Accendra Health’s (ACH) board since March 2022. He is currently CEO of Veritas Veterinary Partners, where he has led a strategy reset and executive rebuild since 2024.

More on Accendra Health

• Accendra Health, Inc. (ACH) Q2 2026 Earnings Call Transcript
• Accendra Health, Inc. 2026 Q2 - Results - Earnings Call Presentation
• Accendra Health Q2 Preview: Low Expectations Create Opportunity
• Accendra Health outlines $2.45B-$2.55B 2026 revenue and $300M-$320M adjusted EBITDA amid cost cuts and CEO retirement plan
• Accendra Health Non-GAAP EPS of -$0.19 misses by $0.10, revenue of $613.2M misses by $14.11M